News & Blog

Endpoints: Touting CD161 as a test case for single-cell tech, Longwood-backed Immunitas bags $58M for next-gen I/O work

Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases

Stanford Medicine: Euan Ashley Appointed the Roger W. and Joelle G. Burnell Professor of Genomics and Precision Health